Post‐marketing dosing changes in the label of biologicals

AIM: The aim of this study was to evaluate post‐marketing label changes in dosing information of biologicals. METHODS: Biologicals authorized between 2007 and 2014 by the European Medicines Agency (EMA) were included and followed up from marketing authorization until 31 December 2016 or date of with...

Descripción completa

Detalles Bibliográficos
Autores principales: Minnema, Lotte A., Giezen, Thijs J., Gardarsdottir, Helga, Egberts, Toine C. G., Leufkens, Hubert G. M., Mantel‐Teeuwisse, Aukje K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422665/
https://www.ncbi.nlm.nih.gov/pubmed/30593087
http://dx.doi.org/10.1111/bcp.13843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422665/
https://www.ncbi.nlm.nih.gov/pubmed/30593087
http://dx.doi.org/10.1111/bcp.13843

Ejemplares similares